The White House budget office is reviewing a proposed rule on Medicaid value-based drug pay that would help states creating value-based payment arrangements. But several legal and practical barriers stand in the way of the successful use of value-based payments to purchase prescription drugs, a recent Health Affairs study finds. The administration’s pending proposed rule would establish minimum standards in state drug-use reviews and support value-based payments for drugs, according to a description of the proposed rule on the Office...